Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial
- 1 September 2003
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 362 (9388), 933-940
- https://doi.org/10.1016/s0140-6736(03)14361-9
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Status of Epidermal Growth Factor Receptor Antagonists in the Biology and Treatment of CancerJournal of Clinical Oncology, 2003
- Targeting epidermal growth factor receptor—are we missing the mark?The Lancet, 2003
- Altered fractionation and combined radio-chemotherapy approaches: pioneering new opportunities in head and neck oncologyEuropean Journal of Cancer, 2003
- Conventional vs modified fractionated radiotherapy. meta-analysis of radiotherapy in head & neck squamous cell carcinoma : a meta-analysis based on individual patient dataInternational Journal of Radiation Oncology*Biology*Physics, 2002
- Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual dataThe Lancet, 2000
- Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizersSeminars in Radiation Oncology, 1996
- Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapyRadiotherapy and Oncology, 1992
- The role of altered fractionation in head and neck cancersSeminars in Radiation Oncology, 1992
- Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: Report from the DAHANCA 2 studyInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Primary radiotherapy of larynx and pharynx carcinoma—An analysis of some factors influencing local control and survivalInternational Journal of Radiation Oncology*Biology*Physics, 1986